News | Mammography | January 19, 2026

More than 1 million DBT studies from three manufacturers paired with biopsy outcome data for 22,000+ patients including more than 7,000 cancer cases.

Vega Curates Largest Digital Breast Tomosynthesis Dataset

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast tomosynthesis (DBT) dataset with paired histology outcomes. The dataset was prepared for a leading developer of AI-based radiology software focused on breast imaging and will support the development of next-generation AI solutions designed to assist in the interpretation of 3D mammography exams. The dataset includes over 1 million DBT studies across three DBT manufacturers, which are paired with biopsy outcome data for more than 22,000 patients, including over 7,000 cancer cases.  All data was de-identified according to 45 C.F.R. § 164.514(b) of the HIPAA Privacy Rule. 

Strengthening AI Performance 

DBT, or 3D mammography, has become an increasingly important technique in breast cancer screening, because it reduces overlapping breast tissue and improves lesion visibility as opposed to traditional 2D mammography techniques. At the same time, DBT exams generate hundreds of image slices per study, increasing interpretation time and cognitive load for radiologists.

By leveraging Vega’s large-scale imaging resources for this project, the AI developer was able to attain superior diversity in its data, which is a key factor in the development of models that are effective across a wide range of breast densities, anatomical variations, and real-world clinical conditions.

Large, Multi-Modal Imaging Datasets

“High-quality, clinically representative imaging data is essential for building AI tools that perform reliably in real-world care settings,” said Luke Bideaux, President and CEO of Vega Imaging Informatics. “This multi-modal dataset demonstrates Vega’s ability to deliver imaging data at scale while meeting the stringent quality, privacy, and compliance standards required for medical AI development. With a single DBT study reaching file sizes over 50 times larger than many other types of imaging studies, such as most chest x-rays, the sheer file size of this dataset demonstrates the scale Vega can achieve in its curation initiatives.” 

Next Generation of Breast Imaging Workflows

AI-enabled DBT interpretation tools are increasingly being adopted to support radiologists through improved workflow efficiency, reducing reading time, and enhancing diagnostic confidence. Increased adoption results in higher demand and competition for AI solutions that can deliver value to breast imaging providers. As the demand for large, high-quality imaging datasets continues to rise, Vega has proven that it is well positioned to meet the needs of the AI development community.

 

For more information visit vegainformatics.com


Related Content

News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
News | FDA

June 25, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...

Time June 25, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Pediatric Imaging

June 16, 2026 — Crescom has officially launched a global clinical Proof of Concept (PoC) of its pediatric ...

Time June 24, 2026
arrow
Subscribe Now